Abstract
The Genetics of Pre-Eclampsia (GOPEC) collaboration aims to identify genetic factors in U.K. families affected by pre-eclampsia. A number of genetic studies have reported associations with pre-eclampsia, but attempts to replicate these findings have yielded inconsistent results. We describe the results of extensive genotyping of seven candidate genes previously reported as conferring susceptibility to pre-eclampsia. Six hundred fifty-seven women affected by pre-eclampsia and their families were genotyped at 28 single-nucleotide polymorphisms in the genes encoding angiotensinogen, the angiotensin receptors, factor V Leiden variant, methylene tetrahydrofolate reductase, nitric oxide synthase, and TNFα. Genotypes were analyzed by the transmission/disequilibrium test. Genotype risk ratios (GRRs) associated with maternal genotypes had a range of 0.70−1.16; GRRs associated with fetal genotypes had a range of 0.72−1.11. No GRR achieved the prespecified criteria for statistical significance (posterior probability >.05). We conclude that none of the genetic variants tested in this large study of strictly defined pre-eclamptic pregnancies confers a high risk of disease. The results emphasize the importance of conducting rigorously designed studies of adequate size to provide precise genetic risks with narrow confidence intervals, if overreporting of falsepositive results is to be avoided.
Original language | English |
---|---|
Pages (from-to) | 127-131 |
Number of pages | 5 |
Journal | American Journal of Human Genetics |
Volume | 77 |
Issue number | 1 |
Early online date | 11 May 2005 |
DOIs | |
Publication status | Published - Jul 2005 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2005 by The American Society of Human Genetics.
ASJC Scopus subject areas
- Genetics
- Genetics(clinical)